Filip Cools, MD, PhD, neonatologist, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Neonatology, Brussels, Belgium
The evidence base is more mechanistic than clinical at this point
431,432 Patients receiving PARP inhibitors had a significantly longer median PFS and a higher ORR than those receiving treatment of the physicians choice
10.3389/fphys.2021.700055 Front
We and others have shown in clinical trials that NAC supplement displays pleiotropic effects against inflammation, vasomotor symptom, and formation of dense red blood cells 14,15
Note that the numbers in parentheses (1, 2, etc.) are clickable links to these studies